Representing Companies In FDA & State Action Enforcement Matters

Eric F. Greenberg, P.C., located in Chicago, Illinois, represents companies throughout the United States before the Food and Drug Administration (FDA) and relevant state department in disputes regarding inspections and violations of food processing, production, growing, and packaging plants, and transportation violations.

When a company has been accused of violating a food and drug law or public health statute, there are potential federal and state enforcement actions, and consumer personal injuries. We represent these companies and help them try to minimize damages and strengthen their company despite injury or violation.

Food & Drug Law, Packaging Law, & Food Contamination

For 30 years we have been helping companies resolved federal, state, and consumer issues regarding food and drug law, and packaging law. We have successfully assisted clients regain market strength and presence. When food poisoning outbreak is alleged to be caused or is caused by your product, i.e., the spinach outbreak, turn to us. We can help you get back into production with FDA approval. We can help you prepare new food, product, and packaging guidelines for prevention of future FDA or state agency violations. And, we will assist in litigation arising from personal injury liability claims.

State Public Health Actions & Federal FDA Actions

It is important to remember that both state and federal laws must be complied with when considering food, drug or packaging standards. Contact Eric F. Greenberg to speak with a food and drug lawyer with 30 years of experience around the country.

Nationwide Representation. Call 312-977-4647

The law firm of Eric F. Greenberg, P.C., located in Chicago, Illinois, represents clients in food and drug law, packaging law, and food chain national security. The attorneys serve clients throughout the United States, from New York to California, Minnesota to Texas.

Food Section

Why Would FDA’s Emergency Actions Stick Around After the Emergency is Over?

Why Would FDA’s Emergency Actions Stick Around After the Emergency is Over?

By Eric F. Greenberg, Attorney-at-law

While some of the Food and Drug Administration’s actions in response to COVID-19 have been traditional, many others have been simplifications of regulatory requirements, and those simplifications could be made permanent.

Here’s one type of activity that was traditional: The agency has been slapping down phony drug products. The moment the COVID-19 pandemic hit the scene, dietary supplement products claiming to cure or prevent the virus started to be offered for sale, and immediately FDA and the Federal Trade Commission started making a regular habit of issuing stern warnings to the makers of the products.

You have questions, We have answers. Request a consult.

Our Office Location

303 East Wacker Drive Suite 305
Chicago, IL 60601

Phone: 312-977-4647